首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

2058255

疫苗佐劑市場：按類型、應用、疾病、應用領域和地區分類

Vaccine Adjuvant Market, By Type, By Usage, By Disease Type, By Application, By Geography

出版日期: 2026年05月11日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，疫苗佐劑市場規模將達到18.1億美元，2033年將達21.3億美元。預計從2026年到2033年，其複合年成長率將達到2.34%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	18.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	2.34%	2033年市場規模預測：	21.3億美元

佐劑是疫苗中的成分，能夠增強人體對疫苗的免疫反應。佐劑的作用在於增強接種者對疫苗的免疫反應。換句話說，佐劑在提高疫苗效力方面發揮重要作用。近年來，人們研發了作用於人體免疫反應特定成分的新型佐劑，提供更強效、更持久的疾病防護。

市場動態

慢性病和感染疾病的日益普及、疫苗佐劑使用量的增加、政府在免疫方面的舉措和政策、COVID-19 大流行以及對開發安全有效疫苗的日益關注，預計將成為推動全球疫苗佐劑市場在預測期內成長的主要因素。

例如，2022 年 10 月，MHRP 及其合作機構啟動了一項 1 期臨床試驗，以評估不同劑量的陸軍 ALFQ 佐劑在 HIV 候選疫苗中的安全性、耐受性和免疫抗原性，從而最佳化佐劑劑量。

此外，2021年8月，Medigen Vaccine Biologics Corporation和Dynavax Technologies Corporation宣布推出其新冠疫苗MVC-COV1901。預計本週將有超過60萬人接種Medigen的疫苗。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據公司亮點、產品系列、主要特點、財務績效和策略等參數，對全球疫苗佐劑市場的主要參與者進行了分析。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球疫苗佐劑市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球疫苗佐劑市場分析中使用的各種策略矩陣，更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Thermo Fisher Scientific Inc.
- Air Liquide（Seppic）
- Pacific GeneTech Limited
- OZ Biosciences
- Novavax Inc.
- Merck & Co. Inc.
- InvivoGen
- GlaxoSmithKline PLC
- Dynavax Technologies Corporation
- CSL Limited
- Croda International PLC
- Vertellus
- Aphios Corporation
- Agenus Inc.
- Adjuvatis
- Associated British Foods PLC（SPI Pharma Inc.）

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1731

Vaccine Adjuvant Market is estimated to be valued at USD 1.81 Bn in 2026 and is expected to reach USD 2.13 Bn by 2033, growing at a compound annual growth rate (CAGR) of 2.34% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1.81 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	2.34%	2033 Value Projection:	USD 2.13 Bn

An adjuvant is a vaccine component that boosts the immune response to the vaccine. An adjuvant is used to create a stronger immune response in people receiving the vaccine. In short, adjuvants help vaccines work better. Newer adjuvants have been developed to target specific components of the body's immune response, so that protection against disease is stronger and lasts longer.

Market Dynamics

Rise in prevalence of chronic/infectious diseases, increasing use of vaccine adjuvants, government initiatives or policies for immunization, outbreak of COVID-19 (pandemic), and increase in focus on the development of safe and effective vaccine are major factors expected to drive growth of the global vaccine adjuvants market over the forecast period.

For instance, in October 2022, MHRP and collaborators recently launched a Phase 1 trial that will evaluate safety, tolerability, and immunogenicity of varying doses of the Army's ALFQ adjuvant in a candidate HIV vaccine to optimize adjuvant dosage.

Furthermore, in August 2021, Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation announced the rollout of its COVID-19 vaccine, MVC-COV1901. More than 600,000 people are anticipated to receive the Medigen vaccine this week.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global vaccine adjuvants market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Air Liquide (Seppic), Pacific GeneTech Limited, OZ Biosciences, Novavax Inc., Merck & Co. Inc., InvivoGen, GlaxoSmithKline PLC, Dynavax Technologies Corporation, CSL Limited, Croda International PLC, Vertellus, Aphios Corporation, Agenus Inc., Adjuvatis, and Associated British Foods PLC (SPI Pharma Inc.)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccine adjuvants market.

Market Segmentation

By Type (Revenue, USD Bn, 2021-2033)
- Mineral Salt-based Adjuvant
- Tensoactive Adjuvants
- Adjuvant Emulsions
- Liposome Adjuvants
- Carbohydrate Adjuvants
- Bacteria-derived Adjuvants
- Virus-like Particles (VLP)
- Other Types
By Usage (Revenue, USD Bn, 2021-2033)
- Active Immunostimulants
- Carriers
By Disease Type (Revenue, USD Bn, 2021-2033)
- Infectious Disease
- Cancer
By Application (Revenue, USD Bn, 2021-2033)
- Research Applications
- Commercial Applications
By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Thermo Fisher Scientific Inc.
- Air Liquide (Seppic)
- Pacific GeneTech Limited
- OZ Biosciences, Novavax Inc.
- Merck & Co. Inc.
- InvivoGen
- GlaxoSmithKline PLC
- Dynavax Technologies Corporation
- CSL Limited
- Croda International PLC
- Vertellus
- Aphios Corporation
- Agenus Inc.
- Adjuvatis
- Associated British Foods PLC (SPI Pharma Inc.)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Usage
- Market Snapshot, By Disease Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Vaccine Adjuvant Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Mineral Salt-based Adjuvant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tensoactive Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Adjuvant Emulsions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Liposome Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Carbohydrate Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Bacteria-derived Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Virus-like Particles (VLP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Other Types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Vaccine Adjuvant Market, By Usage, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Active Immunostimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Carriers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Vaccine Adjuvant Market, By Disease Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Vaccine Adjuvant Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Commercial Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Vaccine Adjuvant Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Usage, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Air Liquide (Seppic)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pacific GeneTech Limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- OZ Biosciences
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novavax Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Merck & Co. Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- InvivoGen
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- GlaxoSmithKline PLC
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Dynavax Technologies Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- CSL Limited
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Croda International PLC
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Vertellus
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Aphios Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Agenus Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Adjuvatis
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Associated British Foods PLC (SPI Pharma Inc.)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views